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Abstract. To study the effector function of the ADP- 
ribosylation factor (ARF) 6 GTP-binding protein, we 
transfected HeLa cells with wild-type, epitope-tagged 
ARF6. Previously shown to indirectly activate the 
ARF1 GTPase, aluminum fluoride (AIF) treatment of 
ARF6-transfected cells resulted in a redistribution of 
both ARF6 and actin to discrete sites on the plasma 
membrane, which became increasingly protrusive over 
time. The effects of A1F were reversible, specific to 
cells transfected with wild-type ARF6, and resembled 
the cellular protrusions observed in cells expressing the 
GTPase defective mutant of ARF6. Importantly, the 
protrusions observed in cells transfected with ARF6 
were distinct from the enhanced stress fibers and mem- 
brane ruffles observed in cells transfected with RhoA 
and Racl, respectively. In cells forming protrusions, 
there was an apparent stimulation of macropinocytosis 
and membrane recycling within the protrusive struc- 
tures. In contrast, no block in transferrin uptake or al- 
teration of the distribution of clathrin AP-2 complexes 
was detected in these cells. The AIF-induced, ARF6- 
dependent formation of protrusive structures was 
blocked by cytochalasin D  and inhibitors of the lipoxy- 
genase pathway. These observations support a novel 
role for the ARF6 GTPase in modeling the plasma 
membrane and underlying cytoskeleton. 
T 
HE actin cytoskeleton is a dynamic, structural com- 
ponent of cells that plays a key role in determining 
cell shape, motility, and cytokinesis. The assembly 
of actin filaments in cells is regulated tightly and, depend- 
ing upon the association with numerous proteins, results in 
a distinctive cellular morphology (Bretscher, 1991; Condee- 
lis, 1993; Stossel, 1993). Two major types of actin arrange- 
ments are found in most mammalian cells. Actin stress fi- 
bers are composed of contractile bundles of actin filaments, 
extending  across  the  cell  and  anchored  to  the  plasma 
membrane at focal adhesions. Additionally, a mesh of cor- 
tical actin filaments is responsible, through assembly and 
disassembly, for forming the transient ruffles and protru- 
sions of cells (Harris, 1989).  Changes in cortical actin can 
be initiated through various signal transduction pathways 
and, as a consequence, result in increased cell motility and 
chemotaxis (Condeelis, 1993; Stossel, 1993; Jamney, 1994). 
The mechanisms whereby extracellular signals are trans- 
duced into specific changes in the actin cytoskeleton re- 
main to be determined. 
An important breakthrough in understanding how the 
actin cytoskeleton could be regulated was the observation 
that Rho-related GTP-binding proteins of the Ras super- 
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family appear to regulate the formation of these structures 
(Hall, 1994; Takai et al., 1995). In Swiss 3T3 cells, evidence 
from microinjection of wild-type and mutant proteins sug- 
gests that RhoA regulates stress fiber formation (Ridley 
and Hall, 1992), while Racl regulates membrane ruffling 
or lamellopodia  (Ridley et al.,  1992).  In Saccharomyces 
cerevisiae, changes in actin distribution and assembly are 
important during vegetative budding, and a series of Rho- 
related GTPases, including Rho and Cdc42 (Adams et al., 
1990), have been implicated in bud site selection. Recently, 
the mammalian homologue of Cdc42 has been identified 
and implicated in the extension of microspikes or filopo- 
dia. In addition, Cdc42 may in turn activate Racl, which 
can then activate RhoA as well (Kozma et al., 1995; Nobes 
and Hall, 1995). Overall, the Rho-related GTPases can be 
activated through plasma membrane signaling pathways, 
including receptor-tyrosine kinases as well as G  protein- 
coupled receptors. 
The ADP-ribosylation factor (ARF) 1 family of proteins 
comprises another group of the Ras superfamily of small 
GTPases, found in all eukaryotes from S. cerevisiae to man 
(Kahn et al., 1991). Named for its role as a cofactor in the 
1. Abbreviations used in this paper:.  A1F, aluminum fluoride; ARF, ADP- 
ribosylation factor; 4BPB, 4-bromophenylacyl bromide; FAK, focal adhe- 
sion kinase; FD, fluorescein dextran; HA, influenza hemagglutinin; LCA, 
lens culinaris agglutinin; NDGA, nordihydroguaretic acid; PLA2, phos- 
pholipase A2; PLD, phospholipase D. 
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and Gilman, 1986), ARFs also have recently been shown 
to stimulate the activity of phospholipase D in in vitro as- 
says  (Brown et al.,  1993;  Cockcroft et al.,  1994), raising 
speculation that ARFs may exert their effects by altering 
phospholipid  metabolism  (Kahn  et  al.,  1993;  Liscovitch 
and Cantley, 1995).  However, such effects have not been 
directly demonstrated in vivo. The ARF1 protein is abun- 
dant in  cells  and  has  been  thoroughly studied  in  whole 
cells and in cell-free biochemical assays (Donaldson and 
Klausner, 1994). It is required for the binding of coatomer 
(COPI) protein to Golgi membranes and is necessary for 
the maintenance of Golgi complex integrity and transport 
along  the  secretory pathway  (Donaldson  and  Klausner, 
1994;  Rothman,  1994).  Less  is  known  about  the  other 
mammalian ARF proteins, although they appear to be ex- 
pressed in all cell and tissue types (Tsuchiya et al., 1991). 
To begin to define the functions of the other ARF pro- 
teins,  we  have  taken  the  approach,  beginning  with  the 
ARF6  protein, of analyzing the localization and  pheno- 
types of transiently expressed, epitope-tagged ARF pro- 
teins and their mutants in mammalian cells (Peters et al., 
1995).  The  validity  of  this  approach  has  been  demon- 
strated  for the  ARF1  protein in  that  overexpression of 
ARF1 and its mutants in cells recreates within the cell the 
phenotypes observed in in vitro biochemical assays  (for 
review see Donaldson and Klausner, 1994). Using this ap- 
proach, we found that the wild-type ARF6 protein is dis- 
tributed  along the  cytoplasmic face of the  plasma  mem- 
brane  and  associated  with  an  internal,  tubulovesicular 
compartment. A  mutant of ARF6 predicted to be defec- 
tive in GTP binding (T27N), and hence predominantly in 
the inactive, GDP state,  is  associated almost exclusively 
with the internal endosome-like structures. Another mu- 
tant of ARF6 predicted to be defective in GTP hydrolysis 
(Q67L), and thus predominantly in the active, GTP state, 
is  confined to the plasma membrane.  Whereas the mor- 
phology of cells expressing wild-type ARF6  protein ap- 
pears normal, the morphology of cells expressing mutant 
forms of ARF6 is altered. Cells expressing T27N exhibit 
an accumulation of ARF6/T27N-positive tubular-endoso- 
mal structures; cells expressing the Q67L mutant exhibit 
an  elaboration of plasma  membrane folds at  peripheral 
edges of these cells (Peters et al., 1995). 
To identify the function of ARF6 and to study the regu- 
lation of its GTP cycle in cells, we turned to approaches 
found to be useful in studying the ARF1 protein. Studies 
with the wild-type ARF1  protein were facilitated by the 
ability to shift the ARF1-GTP cycle in vivo and in vitro 
with  pharmacologic reagents  (Donaldson  and  Klausner, 
1994). Whereas GTP exchange onto ARF1 is specifically 
inhibited by brefeldin A  (Donaldson et al., 1992b;  Helms 
and Rothman, 1992; Randazzo et al., 1993), GTP hydrolysis 
can be inhibited by loading the ARF1 protein with GTP~/S, 
a poorly hydrolyzable analog of GTP, or by treatment of 
intact cells with aluminum fluoride (A1F) (Melanqon et al., 
1987; Donaldson et al.,  1992a;  Robinson and Kreis, 1992; 
Traub et al.,  1993).  Although A1F is a known activator of 
trimeric G  proteins, it has not been shown to activate di- 
rectly any low molecular weight GTPase, including ARF 
(Kahn, 1991). Nevertheless, we have demonstrated that in 
the  presence  of Golgi  membranes,  AIF  acts  to  protect 
ARF1-GTP from GTP hydrolysis, perhaps by inhibiting 
an ARF-GTPase-activating protein, thus inducing stable 
COPI binding to membranes (Finazzi et al., 1994). 
Here we report that treatment of cells overexpressing 
wild-type ARF6 with aluminum fluoride results in the for- 
mation of peripheral plasma membrane protrusions. These 
protrusive structures contain ARF6,  actin, and membra- 
nous folds, and are dynamic structures forming and disas- 
sembling  over a  period  of minutes.  The protrusions  in- 
duced by A1F resemble those observed in cells expressing 
the GTPase-deficient ARF6  mutant,  Q67L. The A1F-in- 
duced  response  is  specific for cells  transfected with  the 
wild-type ARF6 protein, is not observed in cells overex- 
pressing ARF1, and is distinct from the actin rearrange- 
ments  observed  in  cells  overexpressing  Racl  or  RhoA 
proteins. The A1F-induced protrusive structures were not 
formed in the presence of cytochalasin D  or in the pres- 
ence  of compounds  known  to  inhibit  the  lipoxygenase 
branch of arachidonic acid metabolism. Coupled to the dy- 
namic formation of protrusions is an apparent stimulation 
of membrane  turnover via  macropinocytosis. Taken  to- 
gether, these results suggest that ARF6, like the Rho-related 
GTPases, can regulate specific changes  in  plasma  mem- 
brane architecture. 
Materials and Methods 
Reagents,  Cells, and Antibodies 
Iron-saturated transferrin was obtained from Miles Scientific Co. (Naper- 
ville, IL), and lysine-fixable fluorescein dextran (mol wt 10,000)  was pur- 
chased from Molecular Probes, Inc. (Eugene, OR). Rhodamine isothiocy- 
anate-lens culinaris agglutinin (LCA) was purchased from Vector Labs, 
Inc.  (Burlingame, CA).  All other chemicals were  obtained  from Sigma 
Chemical Co. (St. Louis, MO). 
HeLa and COS-7 cells were grown at 37°C in DME supplemented with 
10%  FBS,  100  U/ml penicillin,  100  Ixg/ml streptomycin, and 500  Ixg/ml 
gentamycin sulfate. 
A mouse antibody (12CA5) against the influenza hemagglutinin (HA) 
epitope was purchased from BAbCo (Berkeley, CA), and a mouse anti- 
body to the EE epitope (MEYMPMEHM) was the gift of C.J. Der (Uni- 
versity of North Carolina, Chapel Hill). The following mouse antibodies 
were  obtained  from Sigma Chemical Co.: anti-gelsolin, anti-talin, anti- 
human vinculin. Mouse antibodies to focal adhesion kinase (FAK) and 
cortactin were kindly provided by T. Parsons (University of Virginia Med- 
ical Center, Charlottesville) (Kanner et al., 1990). A mouse mAb, AP6, di- 
rected against the a  subunit of clathrin AP2 (Chin et al., 1989) was kindly 
provided by F. Brodsky (University of California at San Francisco). Rab- 
bit  anti-human transferrin and mouse anti-human transferrin receptor 
(B3/25) serum were purchased from Boehringer Mannheim Biochemicals 
(Indianapolis, IN). Fluorescein- or rhodamine-labeled donkey anti-mouse 
IgG  and donkey anti-rabbit  IgG  were purchased from Jackson Immu- 
noResearch Laboratories (West Grove, PA). 
Rabbit polyclonal antisera was raised against a  peptide, residues 94- 
110 of the ARF6 protein. The antiserum specifically recognizes the ARF6 
protein in transfected cells; the labeling was not observed by immunofluo- 
rescence or immunoblotting in the presence of the immunizing peptide. 
Plasmids and Transient Transfections 
The cDNAs encoding human Rac] and RhoA (0.6 kb) were excised from 
the original pZIP-Neo vectors (obtained from R. Khosravi-Far and C.J. 
Der, University of North  Carolina,  Chapel Hill)  with BamHI and sub- 
cloned  into  the  same modified pCDL-SRc~  expression vector  (termed 
pXS;  Takebe  et  al.,  1988)  used to  express either  wild-type  or  mutant 
ARF6. These Racl  and Rho A  cDNAs contained the nine-amino acid 
epitope tag (MEYMPMEHM; termed EE) (Hawkins et al., 1995). 
HeLa and COS-7 cells grown on glass coverslips were transfected using 
the calcium-phosphate method as previously described (Bonifacino et al., 
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in 10 ml of medium. For six-well dishes, each well received 5 ~g of plasmid 
in 3 mt of medium unless stated otherwise. 36-48 h after transfection, cells 
were treated as described, fixed with 2% formaldehyde in PBS for 10 min 
at room temperature, washed with PBS, and incubated with primary anti- 
bodies diluted in buffer A (10% FBS and 0.02%  azide in PBS) containing 
0.2%  saponin for 1 h at room temperature. Ceils were washed (3 times, 5 
min each) with buffer A and incubated with fluorescently labeled second- 
ary  antibodies  (in  buffer A/0.2%  saponin) for 1 h, washed again,  and 
mounted on glass slides. 
Internalization of Transferrin and Fluid-phase Uptake 
of  Fluorescein-dextran 
For transferrin uptake, transfeeted cells  were rinsed briefly three times 
with 0.5%  BSA in DME, and then incubated in the same medium for 30 
min at 37°C. The cells were then incubated with 30 p,g/ml iron-saturated 
human transferrin either in the presence or absence of 30 mM NaF and 50 
~M A1Cl3 for 30 min at 37°C. The cells were then rinsed twice quickly with 
complete medium (containing 10% FBS), fixed, and processed for indirect 
immunofluorescence as above (Peters et al., 1995). 
To monitor fluid-phase endocytosis, we used fluorescein dextran (mol 
wt 10,000) as a tracer. After various treatments, cells were incubated at 
37°C with 3 mg/ml fluorescein dextran (FD) in complete medium supple- 
mented with 25 mg/ml unlabeled dextran (to reduce nonspecific binding 
of FD to the cell surface). The coverslips were quickly  rinsed to remove 
free FD by immersing several times into complete medium, and then the 
cells were fixed with 2% formaldehyde in PBS for 10 min at room temper- 
ature. The cells were rinsed for 5 min in buffer A, and then the cell surface 
was labeled with 0.5 mg/ml rhodamine-LCA (Vector Labs, Inc.) in buffer 
in the absence of saponin for 30 min. Coverstips were rinsed three times (5 
min each) with buffer A and once with PBS, and then mounted onto slides 
with fluoromount G (Southern Biotechnologies, Birmingham, AL). 
Results 
To begin to study ARF6 function in cells, we looked for 
reagents  that  might  alter  the  distribution  of  wild-type 
ARF6 in transfected cells. We took advantage of the ob- 
servation made previously by us (Donaldson et al., 1992a; 
Finazzi  et  al.,  1994)  and  others  (Melanqon  et  al.,  1987; 
Robinson and Kreis, 1992) that for the ARF1 protein and 
its effector function  (assembly of coat proteins on Golgi 
membranes), treatment of intact cells with A1F, a mixture 
of AIC13, and NaF, could mimic the effects of GTP~/S treat- 
ment of permeabilized cells,  and thus  reveal the  ARF1- 
GTP effector function.  We therefore tested the effect of 
A1F treatment on the distribution of wild-type ARF6 pro- 
tein in transfected cells. 
AIF Induces Surface Protrusions in 
ARF6-transfected Cells 
We  transfected  HeLa cells with  a  plasmid  encoding  the 
wild-type  influenza  hemagglutinin  (HA)-tagged  ARF6 
protein, and then assessed by immunofluorescence the dis- 
tribution of the expressed ARF6 protein with an antibody 
to the HA epitope (12CA5), and the structure of the actin 
cytoskeleton with rhodamine-labeled phalloidin. The ARF6 
protein  was  distributed  along  the  plasma membrane,  in 
microvilli and in focal contact sites at the peripheral edges 
of these polygonal-shaped cells. Additionally, ARF6 was 
observed in  punctate,  endosomal structures.  5  min  after 
addition of A1F, there was an apparent increase in ARF6-HA 
at the peripheral locations, which became more protrusive 
with  time  (Fig.  1).  At  10  rain,  in  addition  to  increased 
ARF6-HA  labeling,  fibrilar,  HA-labeled  structures  ori- 
ented towards these protrusions were also observed. At this 
time,  increased  phalloidin  staining  became  apparent  in 
these protrusive sites.  After a  30-min incubation  in A1F, 
elaborate structures were observed, enriched in ARF6 and 
actin filaments. With further incubation  (120 min), these 
cell  surface  protrusions  became  more  exaggerated  or 
sometimes broadened  into  lamellar  extensions;  at  these 
latter  times,  the  distribution  of the  ARF6-HA  became 
more diffuse. Imaging of live HeLa cells with video mi- 
croscopy  demonstrated  that  the  membrane  protrusions 
formed during the first 60 min of AIF treatment were dy- 
namic  structures;  active  membrane  ruffling  and  protru- 
sions could be observed forming and retracting at a given 
site over a  period  of 5-10 min.  After 60-min  AIF treat- 
ment,  the  protrusive  activity  became  less  dynamic  (not 
shown).  The protrusions were  not observed in  all trans- 
fected cells, but  at any given time could  be observed in 
>50%  of the  transfected cells. The presence of the  HA 
epitope on ARF6 was not responsible for this response to 
AIF since transfection of cells with untagged  ARF6 pro- 
tein elicited the same response (not shown). 
The effects observed with A1F treatment were fully re- 
versible.  When  cells  were  treated  with  A1F  for 30  min, 
washed,  and  incubated  in  fresh  media,  the  protrusions 
were  no  longer  evident,  and  both  ARF6  and  actin  re- 
turned to the initial, untreated distributions within 30 rain 
(not shown). Protrusion formation required that the cells 
be transfected with the wild-type ARF6 plasmid, and thus 
overexpressing the ARF6 protein, since they were not ob- 
served in untransfected HeLa cells. However, in COS cells 
transfected with ARF6, which also demonstrated the same 
response to AIF treatment (data not shown), protrusions 
were observed after A1F treatment in some cells, despite 
an inability to detect the transfected protein with the anti- 
body to HA. Interestingly, by Northern blot analysis, COS 
cells appear to have higher endogenous ARF6 mRNA lev- 
els than  other tissue-culture  cells (Tsuchiya et al.,  1991), 
and  we  have  detected  higher  amounts  of  endogenous 
ARF6 protein in COS as compared with HeLa cells (data 
not shown). These observations suggest that lower expres- 
sion levels of the transfected ARF6, below the level of de- 
tection with the antibody, and possibly endogenous levels 
in  some cell types may be sufficient  to  observe this  re- 
sponse. 
We assessed by immunofluorescence the requirements 
to  observe  the  A1F-induced  surface  projections.  It  re- 
quired energy, as it was not observed under conditions of 
energy depletion  (in the presence of 2-deoxyglucose and 
sodium azide); it required actin polymerization, as it was 
not observed in the presence of cytochalasin D  (see Fig. 
10).  Brefeldin  A  pretreatment,  however, did  not  inhibit 
the  AIF  response,  consistent  with  the  lack  of effect of 
brefeldin A on the distribution of ARF6 in cells (Peters et 
al., 1995). 
Protrusions Induced by AIF Resemble 
Those Formed in Cells Expressing Q67L, the 
GTPase-defective  ARF6 Mutant 
We  next  sought  to  determine  whether  the  morphologic 
change we were observing in A1F-treated, wild-type ARF6- 
expressing cells was similar to the effect of expressing the 
GTPase-defective mutant of ARF6, Q67L, in cells alone. 
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ARF6 protein into the GTP form, then protrusions should 
be observed in  cells expressing the  Q67L mutant. When 
HeLa  cells  were  transfected  with  HA-tagged  Q67L,  as 
early as 16 h, some transfected cells could be observed ex- 
hibiting  membrane protrusions.  By 24  h,  nearly  all cells 
transfected  with  Q67L  elaborated  projections  from  the 
cell  surface  in  the  absence  of  AIF  treatment  (Fig.  2), 
whereas the untransfected HeLa cells remained flattened 
and  polygonal  in  shape.  The  distribution  of  the  Q67L 
ARF6 appeared diffuse in these cells and was not enriched 
in  the  protrusive  structures,  as  was  observed  with  A1F 
treatment of cells expressing the wild-type protein (Fig. 1). 
The diffuse ARF6 localization in the Q67L mutant may be 
a  consequence  of  prolonged,  constitutive  activation  of 
ARF6  in  the  transfected cells.  In support of this, during 
acute activation of wild-type ARF6 with A1F,  crisp local- 
ization of ARF6 and actin within the dynamic protrusive 
structures is observed during the first 60 min of incubation, 
but with extended incubations,  ARF6  and actin localiza- 
tion becomes more diffuse (see Fig.  1; 120 min). The sig- 
nificance of these diffuse localizations during chronic acti- 
vation and in Q67L is not known. 
The transformation of normally polygonal-shaped cells 
into cells forming cell surface protrusions was thus induced 
by the expression of Q67L alone, the ARF6 GTPase-defec- 
tive mutant predicted to be in a constitutively active state. 
The ability of A1F treatment to induce protrusions in cells 
expressing wild-type ARF6, thus approaching the pheno- 
type of Q67L-expressing cells, is consistent with the  AIF 
acting, at least in part, to shift a  portion of the wild-type 
protein into the active, GTP state. 
Protrusion Formation Is Specific for Wild-type 
ARF6 Expression 
The formation of protrusions by AIF treatment was ob- 
served only in cells that were transfected with the  ARF6 
plasmid  and  not  in  untransfected  HeLa  cells.  To  test 
whether this response was specific for the ARF6 wild-type 
protein, we  analyzed the  response to  A1F of HeLa cells 
transfected with mutant forms of ARF6 (Fig. 3). The wild- 
type ARF proteins all contain an amino-terminal consen- 
sus signal for myristoylation, and this lipid modification is 
required  for  biological  activity  in  vivo  (Donaldson  and 
Klausner,  1994).  Cells transfected with an ARF6 mutant, 
in which the myristoylation signal was abolished by substi- 
tuting an alanine residue for a glycine at position 2 (G2A), 
did not form protrusions, as assessed by phalloidin staining 
(not shown), or redistribute the ARF6-G2A protein to pe- 
ripheral sites upon  AIF treatment  (Fig.  3).  Likewise, the 
GTP-binding-defective mutant of ARF6 (T27N) localized 
in cells to punctate endosomal structures, as observed pre- 
viously (Peters  et  al.,  1995),  but  neither  redistributed  to 
Figure 2.  Expression of Q67L, the constitutively active mutant of 
ARF6, in cells induces  cell protrusions.  HeLa cells were trans- 
fected with plasmid encoding HA-tagged Q67L mutant of ARF6. 
24 h after transfection,  the cells were fixed and labeled for immu- 
nofluorescence  as in Fig. 1. Cellular  protrusions  and surface ex- 
tensions can be observed emanating from the transfected cells. 
peripheral sites during A1F treatment (Fig. 3) nor showed 
any  changes  in  actin  distribution  (not  shown).  Unfortu- 
nately, the T27N mutant of ARF6, although inactive, did 
not reveal a dominant, negative phenotype; in cotransfec- 
tion experiments with wild-type ARF6, T27N did not in- 
hibit the AIF-induced redistribution of wild-type ARF6 to, 
and formation of, protrusive structures (not shown). These 
experiments demonstrate that to induce membrane exten- 
sions, the ARF6 protein expressed must be myristoylated 
and capable of GTP binding. 
The formation of protrusions in response to AIF was not 
observed in cells overexpressing other ARF family mem- 
bers.  Previous in  vivo and  in  vitro  studies  have  demon- 
strated the Golgi localization and functioning of the ARF1 
protein (Donaldson and Klausner, 1994).  When we trans- 
fected  HeLa cells with  wild-type  ARF1  protein,  we  ob- 
served ARF1 localized to the Golgi complex (Fig. 3), con- 
sistent  with  previous  studies  (Dascher  and  Balch,  1994; 
Teal et al., 1994). Treatment of these cells with AIF did not 
significantly alter ARF1 Golgi localization and did not in- 
duce  the  formation  of protrusions.  The  inability  of the 
Figure 1.  Aluminum fluoride induces cell surface protrusions in ARF6-transfected cells. HeLa cells transiently  transfected with ARF6- 
HA were treated for various times with 30 mM NaF and 50 v.M AICI3 (AIF) at 37°C, and then fixed with 2% formaldehyde. Cells were 
then immunolabeled with a mouse anti-HA antibody followed by fluorescein-labeled  donkey anti-mouse IgG and rhodamine-labeled 
phalloidin  to visualize actin filaments.  In untreated cells (AIF 0 rnin), ARF6 localized to the plasma membrane and internal punctate 
structures. Treatment with AIF resulted in a time-dependent concentration of ARF6 at discrete sites along the plasma membrane, which 
became increasingly protrusive over time. After an initial lag, actin filaments also became increasingly concentrated in these protrusions 
where it colocalized with ARF6. Note that ARF6 recruitment to these protrusions preceded that of actin. 
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HA epitope-tagged wild-type  ARF6, ARF6/G2A, ARF6/T27N,  or ARF1  were incubated in the presence (+AIF) or absence (Un- 
treated) of AIF for 30 min, fixed, and processed for indirect immunofluorescence.  AIF treatment induced protrusions  only in cells trans- 
fected with wild-type ARF6. 
ARF1 protein when overexpressed to mimic the function 
of the ARF6 protein is consistent with the inability of the 
ARF6 protein to substitute for ARF1 functioning in cells, 
as observed previously (Peters et al.,  1995).  Transfection 
of cells  with  ARF5,  an  ARF  protein  whose  localization 
and  function  has not  been defined,  did  not  result  in  the 
formation of protrusions  upon  AIF treatment  (data  not 
shown).  The inability of ARF1  and  ARF5  to  mimic the 
role of ARF6 in these responses confirms the distinct roles 
for the different ARF family members. 
ARF6-dependent Effects Are Distinct  from Those of the 
Rho-related GTPases 
Since  the  Rho-related  GTPases  RhoA  and  Racl  have 
been shown to regulate the formation of stress fibers and 
cortical membrane ruffles in eukaryotic cells (Ridley and 
Hall, 1992; Ridley et al., 1992), it was important to investi- 
gate whether the  actin structures induced  in response to 
AIF in ARF6-overexpressing cells were specific to ARF6 
and distinct from actin structures observed in cells overex- 
pressing Rho or Rac proteins. Accordingly, we expressed 
RhoA and Racl proteins in HeLa cells. Overexpression of 
RhoA in HeLa cells resulted in cells containing numerous, 
tightly arrayed actin stress fibers; this morphology did not 
appreciably change in response to AIF (not shown). 
The Racl protein was diffusely distributed in untreated 
cells overexpressing Racl (Fig. 4). Treatment of these cells 
with AIF, however, resulted in a distinctive redistribution 
of both Rac and actin staining to membrane folds present 
over the  surface of the  cell. This phenotype approached 
that of cells transfected with the GTPase-defective mutant 
of Rac (Q61L) where numerous membrane folds and ruf- 
fles were observed on the surface of the transfected cells, 
labeled by both anti-Rac antibody and phalloidin.  These 
membrane ruffles, observed in HeLa cells, were reminis- 
cent, in part, of the ruffling response observed in serum- 
starved Swiss 3T3 cells microinjected with  activated Rac 
proteins (Ridley et al., 1992). The structure of these actin- 
rich  plasma  membrane  alterations  was  clearly  different 
from that  seen in  ARF6-transfected  cells.  Whereas  acti- 
vated Rac resulted in numerous membrane folds over the 
entire surface of the membrane, activated ARF6 induced 
folds of membrane at discrete sites around the periphery 
of the cells, protruding outward. 
Characterization  of AIF-induced Surface Protrusions 
Rapid changes in cell shapes, such as the extension of the 
protrusions observed in  the  ARF6 transfected cells, usu- 
ally involve the  activation and  recruitment  of numerous 
signaling molecules, as well as actin-associated proteins in- 
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lopodia  in  HeLa  cells  expressing  wild-type  Rac  1.  HeLa  cells 
were  transiently  transfected  with  plasmids  encoding  either  EE 
epitope-tagged  wild-type  Racl  or Rac1/Q61L.  Cells  expressing 
wild-type  Racl  were  incubated  either  with  (+All=)  or without 
(Untreated) A1F for 30 min, fixed, and stained with a mouse anti- 
EE epitope antibody followed by fluorescein donkey anti-mouse 
IgG and  rhodamine-phalloidin.  The  Racl  protein  was  diffusely 
distributed  in untreated  cells. The addition of AIF to these cells 
resulted in the formation of extensive membrane folds over the 
top of the cell, similar to those observed in cells expressing the 
GTPase-defective Racl/Q61L mutant. 
volved in  actin  disassembly  and  reassembly (Condeelis, 
1993; Stossel, 1993; Jamney, 1994). We examined whether 
such  proteins  were  recruited  into  the  protrusions  in 
ARF6-transfected  cells.  In  untreated  cells,  the  calcium- 
regulated,  actin-severing  and  capping  protein,  gelsolin, 
colocalized  with  ARF6,  particularly  at  the  peripheral 
edges of transfected cells, but importantly, gelsolin distri- 
bution  was not  disturbed  by overexpression of wild-type 
ARF6.  After treatment with  A1F,  gelsolin was redistrib- 
uted to the protrusions along with ARF6  (Fig. 5), with a 
similar  time  course,  preceding  the  recruitment  of  actin. 
We also examined the distribution  of proteins associated 
with focal adhesions,  sites of contact between actin stress 
fibers and  the  plasma membrane.  FAK  was  localized  in 
untreated  cells  to  focal  adhesions,  some  of which  were 
positive for ARF6, especially at peripheral edges of cells. 
The extent of this colocalization increased upon A1F treat- 
ment  (Fig.  6).  Cortactin,  a  substrate  phosphorylated  by 
FAK, was observed to be mostly diffuse in untreated cells, 
regardless  of whether  they  were  transfected;  AIF  treat- 
ment induced  a  marked redistribution  and concentration 
of cortactin  in  the  protrusive  structures  (Fig.  6).  In  un- 
transfected  cells,  the  distribution  of gelsolin,  FAK,  and 
cortactin  was not  significantly altered  by A1F treatment. 
The protrusions were also labeled heavily with antibody to 
phosphotyrosine  residues  (not  shown),  indicative  of the 
activation of kinases such as FAK during AIF stimulation 
of the  cells.  Although gelsolin, FAK, and cortactin were 
clearly concentrated  in  these  protrusions,  other  proteins 
such  as  talin  and  vinculin  were  not  specifically concen- 
trated there (not shown). 
The AIF-induced Membrane Protrusions Are 
Sites of Enhanced Macropinocytosis  and Are Devoid 
of Clathrin 
The  abundance  of multilamellar  folds  within  the  mem- 
brane protrusions  in  ARF6-transfected  cells and  the  dy- 
namic nature  of these  structures  prompted  us  to  ask  to 
what  extent  plasma  membrane  traffic  events  were  re- 
quired  or  altered  during  A1F  treatment.  Since  sites  of 
plasma membrane ruffling often  exhibit  enhanced  fluid- 
phase pinocytosis (Steinman et al., 1983; Bar-Sagi and Fe- 
ramisco, 1986), we examined the fluid-phase uptake of FD 
into ceils incubated in the presence or absence of A1F. The 
protrusions in transfected cells were visualized by labeling 
the surface with rhodamine-labeled LCA (Fig. 7) after fix- 
ation. 
In  the  absence  of AIF, FD  was  observed in  scattered 
punctate  structures  after  a  10-rain  incubation  in  both 
transfected and untransfected cells. The FD redistributed 
to larger structures in the perinuclear region upon further 
incubation (see, e.g., Fig. 7 B). This pattern of fluid-phase 
uptake  is  typical  and  has  been  described  for  many cell 
types (van Deurs et al., 1989; Watts and Marsh, 1992). 
We next assessed the uptake of FD into transfected (Fig. 
7 A) and untransfected (Fig. 7 B) cells pretreated with A1F 
for 30 rain. FD was rapidly internalized within  1 rain into 
large, discrete structures within the membrane protrusions 
of transfected  cells  treated  with  A1F  (Fig.  7  A).  These 
structures were reminiscent of macropinosomes that have 
been described in  a number of cell types (Hewlett et al., 
1994;  Racoosin and Swanson, 1992).  The number of mac- 
ropinosomes  increased  after  10  rain  of loading  with  FD 
and  remained  mostly  localized  within  the  protrusions. 
Smaller,  punctate  spots  were  also  scattered  throughout 
these cells but are not visible in this exposure, which was 
optimized to visualize the loading into the protrusions. FD 
was clearly internalized into these protrusive sites and not 
merely entrapped within the membranous folds, since no 
labeling was observed in  cells incubated  with FD  at 4°C 
(not  shown).  If cells  were  labeled  with  FD  for  10  rain, 
rinsed, and then incubated in media containing AIF but no 
FD for 30 rain, the FD was no longer associated with the 
visible protrusions and had apparently been released from 
the cells (Fig. 6 A). The FD remaining in the cell was local- 
ized in punctate structures in the perinuclear region. 
In contrast with the rapid uptake and release of dextran 
in  cells  forming  protrusions,  untransfected  HeLa  cells 
treated with A1F showed no detectable uptake of FD after 
a 1-min incubation with FD, and after 10 rain, small punc- 
rate structures were observed scattered about the cell pe- 
riphery (Fig.  7 B),  which  moved into  the  perinuclear re- 
gion after a 30-rain chase in media without dextran. Thus, 
although  fluid  uptake  was  the  same  in  both  transfected 
and untransfected cells in the absence of A1F, there was a 
clear  change  in  the  pattern  of  uptake  and  recycling  of 
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izes  with  ARF6  in  trans- 
fected cells and redistributes 
to protrusive sites during AIF 
treatment.  ARF6-transfected 
HeLa  cells  were  incubated 
for  30  min  in  the  absence 
(Untreated)  or  presence 
(+All)  of  AIF,  fixed,  and 
processed  for  immunofluo- 
rescence.  Cells were labeled 
with  a  mouse  antibody  to 
gelsolin  and rabbit antibody 
to  an  ARF6  peptide,  fol- 
lowed  by  appropriately  la- 
beled  second  antibodies. 
Gelsolin  colocalizes  with 
ARF6, particularly  at the pe- 
ripheral sites around the cell, 
and redistributes  along  with 
ARF6 to protrusive sites. 
membrane and fluid within the membrane protrusions in 
AIF-treated, ARF6-transfected cells. 
Given the  apparent increase  in  fluid  internalization  in 
cells forming protrusions, we investigated whether recep- 
tor-mediated endocytosis was altered in these cells. We ex- 
amined  the  internalization  of human  transferrin  in  cells 
overexpressing ARF6 in the presence and absence of AIF, 
using immunofluorescence. In the  absence of AIF, trans- 
ferrin taken up after a 30-min incubation was observed in 
scattered,  punctate  structures  with  increasing  concentra- 
tion of these structures around the nucleus  (Fig. 8). This 
distribution  was  the  same  for  both  transfected  and  un- 
transfected cells and was similar to what was observed for 
the distribution of the transferrin receptor (not shown). In 
the  presence  of  A1F,  transferrin  was  again  observed  in 
structures around the nucleus in both transfected and un- 
transfected cells (Fig. 8). In transfected, protrusion-form- 
ing cells, transferrin could also be observed diffusely label- 
ing  the  protrusions.  Similar  results  were  obtained  when 
cells were pretreated with AIF for 30 min before the addi- 
tion of transferrin and continued incubation with A1F for 
an additional 30 min. Importantly, neither overexpression 
of ARF6 nor A1F treatment blocked transferrin uptake as 
monitored by immunofluorescence. 
The diffuse transferrin labeling of the protrusions prompted 
us to ask whether internalization of transferrin via clathrin- 
coated  pits  occurred  in  these  protrusions  or  elsewhere 
along the cell surface. To address this, we examined the 
distribution of clathrin-coated pits along the plasma mem- 
brane in ARF6-transfected cells by monitoring the clath- 
rin-associated  protein, AP-2.  We found AP-2 distributed 
evenly along the plasma membrane in a punctate distribu- 
tion in all untreated cells, and this distribution was not al- 
tered in cells forming protrusions with A1F treatment (Fig. 
9). A  similar lack of effect of AIF treatment on the distri- 
bution  of caveolin  was  also  observed  (not  shown).  The 
lack  of  any  apparent  "concentration"  of  these  plasma 
membrane-associated  coat  proteins  in  the  overlapping 
membrane folds of the protrusions suggests that clathrin- 
coated plasma membrane and  caveolin were, in fact, ex- 
cluded from the protrusive regions. Interestingly, in cells 
expressing the  constitutively active ARF6  mutant  Q67L, 
the membranous folds observed in these cells by EM are 
also  largely devoid of clathrin-coated  pits  (Peters  et  al., 
1995). 
Inhibitors of  Arachidonic Acid Metabolism Block the 
AIF-induced Protrusions 
We searched for reagents that would either inhibit or en- 
hance  the  AIF-stimulated  formation  of protrusions.  We 
saw no effect of inhibiting protein or lipid kinases or phos- 
phatases using such reagents as staurosporine,  genistein, 
wortmanin, and okadaic acid (not shown). 
A  recent  study  demonstrated  that  the  growth  factor- 
induced  stimulation  of stress fiber  formation is  signaled 
through  Rac and then  Rho via arachidonic  acid metabo- 
lites, specifically leukotrienes (Peppelenbosch et al., 1995). 
After its release from membrane lipids by phospholipase 
A2  (PLA2),  arachidonic  acid  is metabolized by two dis- 
tinct pathways: the cyclooxygenase pathway leading to the 
production of prostaglandins, and the  lipoxygenase path- 
way leading to the formation of leukotrienes and eicosanoids. 
In a previous study, Peppelenbosch et al. (1993) had dem- 
onstrated  that growth  factor-induced  stress fiber forma- 
tion was blocked in the presence of specific inhibitors  of 
the lipoxygenase pathway but not by inhibitors of the cy- 
clooxygenase pathways. 
We  investigated  whether  arachidonic  acid  metabolism 
was involved in  the  A1F-stimulated  formation of surface 
protrusions  in  ARF6-overexpressing cells.  For  these  ex- 
periments, HeLa cells transfected with ARF6 were prein- 
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arachidonic acid release and leukotriene production was 
also necessary for the continued formation of protrusions, 
since addition of 4BPB or NDGA to cells pretreated for 
30 min with A1F reversed protrusive activity (not shown). 
Figure 6.  FAK and its substrate  cortactin redistribute  to protru- 
sions during AIF treatment. ARF6-transfected  HeLa cells were 
incubated  for 30 min  in  the  absence  (Untreated)  or presence 
(+AIF) of AIF, fixed, and processed for double-label immunoflu- 
orescence.  Cells were stained  with  mouse antibodies  to either 
FAK or cortactin  and with ARF6-specific rabbit antiserum, fol- 
lowed  by appropriately labeled  donkey secondary antibodies. 
FAK localized to focal adhesions in untreated cells, but redistrib- 
uted to protrusions upon AIF treatment. Cortactin was diffusely 
distributed  in untreated cells, but also redistributed  to protru- 
sions in A1F-treated cells. 
cubated for 10 min in serum-free media containing inhibi- 
tors of arachidonic acid metabolism, followed by a 30-min 
incubation with A1F. Preincubation with 4-bromophenyl- 
acyl bromide (4BPB) (20 IxM), an inhibitor of PLA2 (Rains- 
ford, 1988), completely prevented protrusions induced by 
A1F (Fig. 10). ARF6-HA was distributed in a fine punctate 
pattern with neither concentration at peripheral sites nor 
significant colocalization with phalloidin.  Actin stress fi- 
bers were still apparent, but they had a beaded appearance 
in all cells, even before AIF addition. Having shown the 
requirement  for  arachidonic  acid  release  by  PLA2,  we 
next tested the effect of specific inhibitors for each path- 
way. Inhibition of 5-1ipoxygenase by nordihydroguaretic 
acid  (NDGA)  (20  IxM)  (Rainsford,  1988)  also  blocked 
AIF-stimulated protrusions and ARF6 redistribution. This 
inhibition could also be observed at 5 vtM NDGA if cells 
had been serum starved for 16 h beforehand. In contrast, 
preincubation with indomethacin (20 I~M), an inhibitor of 
cyclooxygenase, had no apparent effect on ARF6 redistri- 
Discussion 
The ARF family of GTP-binding proteins is believed to 
function as regulators of membrane traffic and organelle 
structure. The function of the ARF1 protein has been well 
characterized; it reversibly associates with membranes of 
the Golgi complex and is required to assemble, in a GTP- 
dependent  manner,  the  cytosolic coat  complex,  COPI, 
onto Golgi membranes. The regulated coating and uncoat- 
ing  of Golgi  membrane  is  necessary to  allow  transport 
through the Golgi complex and the maintenance of Golgi 
organellar structure (Donaldson and Klausner,  1994).  In 
contrast with ARF1, defining specific cellular functions for 
the  other  ARF  family members  has  yet  to  be  accom- 
plished. 
Here we report on a novel role for the ARF6 GTPase at 
the cell surface that is distinct from the role of ARF1  at 
the Golgi complex. The ability of AIF to reversibly induce 
cell  surface,  actin-enriched  protrusions  in  cells  overex- 
pressing  the  wild-type ARF6  protein, similar  to  protru- 
sions observed in cells expressing the constitutively active, 
ARF6  mutant  (Q67L),  suggests  that  ARF6,  through  its 
GTP cycle, may play a  role in  determining cell surface 
morphology. As ARF1 regulates organelle structure at the 
Golgi complex, it is possible that ARF6 serves a  similar 
function at the plasma membrane. 
In this study, we show that cells overexpressing the wild- 
type ARF6  protein  form dynamic,  multilamellar,  actin- 
rich protrusions in response to acute treatment with A1F. 
A number of observations suggest that the A1F treatment 
is acting, in part, to shift the nucleotide status of the ARF6 
protein  into  the  GTP state,  enabling  us  to  observe the 
ARF6 effector function. First, protrusions are formed with 
AIF  treatment  only in  cells  expressing  wild-type ARF6 
protein, capable of being activated with GTP, and not in 
cells  expressing  nonmyristoylated ARF6  (G2A)  or  the 
GTP-binding-defective mutant  (T27N),  and  not  in  cells 
overexpressing wild-type ARF1 or ARF5 (Fig. 3). Second, 
the cellular protrusions exhibited by cells treated with A1F 
resemble  protrusions  observed  in  cells  expressing  the 
GTPase-defective mutant of ARF6, Q67L (Fig. 2). Immu- 
noelectron microscopy has confirmed that 30 min of A1F 
treatment of cells expressing wild-type ARF6 results in in- 
creased localization of ARF6 at the plasma membrane and 
the extension of numerous plasma membrane folds (Pe- 
ters,  P.,  personal  communication)  resembling the  mem- 
brane elaborations observed, by EM, in  cells expressing 
the constitutively active Q67L mutant (Peters et al., 1995). 
Finally, and remarkably, we observed that AIF treatment 
had a similar activating effect on cells overexpressing an- 
other  GTPase  implicated  in  actin  rearrangements,  the 
Racl protein. A1F treatment induced membrane ruffles in 
cells  overexpressing Racl,  similar  to  those  observed  in 
cells expressing the constitutively active, Q61L Rac mu- 
tant (Fig. 4). Thus, for both ARF6 and Racl in this system, 
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(A) and untransfected (B) HeLa cells were treated with A1F for 30 min, and then 3 mg/ml FD was added for 1 min, 10 min, or 10 min fol- 
lowed by a 30-min chase in the absence of FD but continued presence of A1F. The cells were fixed, and the surface was labeled with 
rhodamine-labeled lens culinaris aglutinin (LCA). 
AIF treatment  appears  to result  in  a  phenotypic shift  to 
the  GTP-active form. Confirmation of this point will  re- 
quire determining the guanine nucleotide state of ARF6 in 
the cell after AIF treatment, currently under investigation. 
Although the cell surface protrusions observed in AIF- 
treated  cells  transfected  with  the  wild-type  ARF6 were 
similar to those observed in cells expressing the constitu- 
tively active ARF6, Q67L, they were not identical. It is not 
surprising  that  the  phenotypes  observed  in  the  two  in- 
stances would not be the same. In one case, normal, poly- 
gonal-shaped cells expressing wild-type ARF6, which can 
cycle between a GTP- and GDP-bound state, are treated 
with AIF, which presumably results in an acute shift to the 
GTP-active state and the formation of surface protrusions. 
A1F is probably also activating other signaling pathways in 
the cells, some of which may enhance the protrusive activ- 
ities of the transfected cells during A1F treatment. In con- 
trast, cells expressing Q67L, the GTPase-defective mutant, 
are expressing an ARF6 that is locked into the GTP-active 
state. Expression of this irreversibly active mutant does re- 
sult in the formation of protrusions early in the transfec- 
tion, but other aspects of the cell morphology and the dif- 
fuseness of the Q67L localization are difficult to interpret. 
It is for these reasons that we favor studying ARF6 func- 
tion in cells expressing the wild-type protein, where the in- 
duction of protrusive activity in these cells by A1F is rapid 
at the onset and is reversible, enabling us to study the full 
GTP cycle of the ARF6 protein. 
The cellular target, or targets, of A1F involved in the for- 
mation  of these  cellular  protrusions  is  not  known.  Al- 
though AIF has been shown to directly activate trimeric G 
proteins  when  GDP is  bound to the  a  subunit  (Higash- 
ijima et  al.,  1991),  there is no evidence that AIF can di- 
rectly activate any low molecular weight GTPase in  this 
manner  (Kahn,  1991).  Nevertheless,  AIF treatment  has 
been shown to protect ARFI-GTP from GTP hydrolysis 
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ARF6-expressing cells. Transfected cells were incubated at 37°C 
with 30 ~g/ml iron-saturated human transferrin for 30 min either 
in the absence (Untreated) or presence (+AIF) of A1F, fixed, and 
processed for immunofiuorescences. ARF6 was  labeled with a 
mouse anti-HA antibody and transferrin was labeled with rabbit 
antiserum to human transferrin. 
in vitro, in the presence of Golgi membranes (Finazzi et 
al., 1994). Given the many examples where actin changes 
are induced by G  protein-coupled receptors (see Stossel, 
1993)  and other observations made suggesting a  link be- 
tween  ARF and trimeric G  proteins  (Donaldson et  al., 
Figure 10.  Stimulation of protrusions by AIF is blocked by inhib- 
itors of actin polymerization and arachidonic acid  metabolism. 
Transfected HeLa cells expressing wild-type ARF6-HA were ei- 
ther not preincubated (AIF alone) or preincubated for 10 min 
with 0.2  ixM cytochalasin D  (Cyto  D)  or with  20  IxM 4-BPB, 
NDGA, or indomethacin before incubation  with AIF for an addi- 
tional 30 min. Cells were fixed and processed for immunofluores- 
cence.  Protrusions were  easily detectable in ARF6-expressing 
cells treated with A1F alone or those treated with the cyclooxyge- 
nase inhibitor, indomethacin. In contrast, treatment of cells with 
Cyto D, the PLA2 inhibitor, 4-BPB, or the lipoxygenase inhibi- 
tor, NDGA, completely inhibited the formation of protrusions in 
response to AIF stimulation. 
Figure 9.  The plasma membrane clathrin adaptors, AP-2, are not 
redistributed  to  protrusions during A1F  treatment  of  ARF6- 
expressing cells. Transfected cells were untreated or treated with 
AIF (+AIF) for 30 rain at 37°C, fixed, and processed for double- 
label immunofluorescence. Cells were stained with rabbit anti- 
ARF6 serum and a mouse antibody to cc-adaptin, followed by 
appropriate fluorescently labeled donkey antibodies. AP-2 was 
distributed in a discrete punctate pattern, which did not become 
concentrated in protrusions after the addition of A1F (arrow). 
1991; Ktistakis et al., 1992; Colombo et al., 1995), it seems 
reasonable  to  ascribe  a  G  protein  involvement in  the 
mechanism whereby A1F causes formation of these protru- 
sions in ARF6-expressing cells. However, fluoride ions in 
combination  with aluminum  can also affect various ATPases 
and phosphatases (Chabre, 1990). Regardless of the mech- 
anism of action of A1F and the potential A1F targets, the 
response we are monitoring is selective, only observed in 
cells overexpressing the wild-type ARF6 and thus ARF6 
dependent, and is fully reversible. 
The  A1F-induced, ARF6-dependent protrusion forma- 
tion was blocked by inhibitors of arachidonic acid metabo- 
lism. The inhibition by NDGA, and not by indomethacin, 
suggests that the lipoxygenase arm of arachidonic acid me- 
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quired to couple the AIF stimulation of the cells to the for- 
mation of protrusions. Prostaglandin synthesis through the 
cyclooxygenase pathway does not appear to be necessary. 
Blockage of the pathway further upstream, by 4BPB, an 
inhibitor of PLA2, independently suggests the importance 
of  this  biochemical  pathway  for  AIF-induced,  ARF6- 
dependent protrusive structures. The significance of these 
observations, as well as their specific role in this response, 
will require further studies. 
This study implicates the involvement of ARF6, a non- 
Rho-related GTPase, in cytoskeletal rearrangements that 
lead to the formation of cell surface protrusions. Previous 
studies of Hall and colleagues (Hall, 1994) have demon- 
strated that specific Rho-related GTPases regulate the for- 
mation  of distinctive,  actin-dependent  structures.  Thus, 
Cdc42 activation is associated with filopodia, Racl  with 
lamellopodia, and RhoA with stress fiber formation. 
The protrusions  formed in  ARF6-expressing cells  are 
distinct from membrane ruffling observed in Rac-express- 
ing cells. ARF6-dependent protrusions were not directly 
dependent upon  Rac, based  on the inability of the  Rac 
GTP-binding-defective (T17N) mutant  to inhibit  ARF6 
function (unpublished observations). However, we cannot 
rule  out indirect effects or crosstalk between these  two 
GTPases.  Unfortunately, since the ARF6  GTP-binding- 
defective mutant, T27N, is not a  dominant-negative mu- 
tant, we could not assess  whether the Rac response was 
dependent upon ARF6 function. The observation that the 
three Rho GTPases can act either in a cascade or individu- 
ally  through  selective  stimulation  (Kozma  et  al.,  1995; 
Nobes and Hall, 1995) attests to the complexity of interac- 
tion of these cytoskeletal regulators. Identification of the 
cellular targets for cdc42, Rac, Rho, and ARF6 may clarify 
the  mechanisms  whereby they orchestrate these  specific 
actin filament rearrangements. 
The specific biochemical activities regulated by ARF6 
are  not  known.  The  demonstration  that  ARF  activates 
phospholipase  D  (PLD)  when  added  to  permeabilized 
cells (Cockcroft et al.,  1994), to partially purified enzyme 
preparations (Brown et al., 1993), and, more recently, to 
cloned,  recombinant  human  PLD1  (Hammond  et  al., 
1995) has raised the possibility that ARFs may be func- 
tioning in cells by affecting phospholipid metabolism. The 
stimulation of PLD activity has been observed using re- 
combinant  ARFs  1,  5,  and 6  (Massenburg  et al.,  1994), 
raising  the  possibility  that  ARF6  may  function  in  cells 
through its effects on PLD. The positioning of ARF6 at 
the plasma membrane makes it a prime candidate as a po- 
tential activator of PLD in response to agonist and growth 
factor stimulation.  Further  investigations  are  needed  to 
address this possibility. 
During A1F-induced protrusion formation, we observed 
a  stimulation  of fluid  uptake  by  macropinocytosis.  Al- 
though  the  association  of  stimulated  macropinocytosis 
with active membrane ruffling is well documented (Bar- 
Sagi and Feramisco, 1986;  Racoosin and Swanson,  1992; 
Swanson and Watts, 1995), its physiological significance is 
unclear. In our studies, fluid internalized into macropino- 
somes was not further transported into the cell, but was 
apparently  released  back  out  into  the  media.  The  high 
concentration of F-actin within the protrusions may be a 
barrier to  the  further transport  of the  macropinosomes 
into the cell. In our system, this membrane pathway of 
stimulated  fluid  internalization  and  release  may  be  in- 
volved in  coordinating the  observed changes  in  plasma 
membrane morphology with the dynamic assembly/disas- 
sembly of actin to form these protrusions. How this regu- 
lated pathway of macropinocytosis relates to that of recep- 
tor-mediated  endocytosis is  a  topic  of current  research 
(Hansen et al., 1993; Hewlett et al., 1994) and discussions 
(Sandvig and van Deurs, 1994; Lamaze and Schmid, 1995). 
In contrast with the stimulation of macropinocytosis ob- 
served in cells forming protrusions, we did not detect an 
alteration in the  uptake of transferrin either by overex- 
pression of wild-type ARF6 alone or during AIF treatment 
using immunofluorescence. On the other hand, D'Souza- 
Schorey et al.  (1995) reported, using a quantitative assay, 
an inhibition of transferrin uptake associated with overex- 
pression of either wild-type ARF6 alone or the Q67L mu- 
tant of ARF6 in CHO cells. A direct comparison between 
the two studies is difficult given the different cell types, ex- 
pression systems, and assays used. It is possible that the in- 
creased membrane cycling due to macropinocytosis, as re- 
ported here, under certain circumstances, could have effects 
on the endosomal-transferrin cycle, but we could not de- 
tect such changes. The observation that endosomally asso- 
ciated ARF6  only partially overlaps with  the transferrin 
receptor (Peters et al., 1995) suggests that the membranes 
through which ARF6 cycles may partially overlap between 
these two cycling membrane systems. Further studies will 
be needed to resolve these differences. 
In this study, we describe a novel function for an ARF 
GTP-binding protein, i.e., initiating rearrangements of the 
actin cytoskeleton and plasma membrane to generate cell 
surface  protrusions.  Thus,  ARF6  and  the  Rho-related 
GTPases may specifically regulate distinctive actin-based 
cell surface structures. The differential regulation of the 
activity of these GTPases, in conjunction with the assem- 
bly of numerous structural proteins, will ultimately deter- 
mine cellular morphology. Defining the pathways whereby 
each GTPase functions, the regulation of actin assembly, 
and the role of membrane traffic in the modeling of the 
cell surface will provide a  major challenge to cell biolo- 
gists. 
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Marks, C. Ooi, and J. Song for critical  reading of the manuscript. 
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